File:Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness.pdf

From Meta, a Wikimedia project coordination wiki
Go to page
next page →
next page →
next page →

Original file(1,275 × 1,650 pixels, file size: 1.1 MB, MIME type: application/pdf, 18 pages)

This is a file from the Wikimedia Commons. The description on its description page there is copied below.

Summary

Description
English: Objective

Studies have demonstrated a potential correlation between low vitamin D status and both an increased risk of infection with SARS-CoV-2 and poorer clinical outcomes. This retrospective study examines if, and to what degree, a relationship exists between pre-infection serum 25-hydroxyvitamin D (25(OH)D) level and disease severity and mortality due to SARS-CoV-2.

Participants

The records of individuals admitted between April 7 th, 2020 and February 4 th, 2021 to the Galilee Medical Center (GMC) in Nahariya, Israel, with positive polymerase chain reaction (PCR) tests for SARS-CoV-2 (COVID-19) were searched for historical 25(OH)D levels measured 14 to 730 days prior to the positive PCR test.

Design

Patients admitted to GMC with COVID-19 were categorized according to disease severity and level of 25(OH)D. An association between pre-infection 25(OH)D levels, divided between four categories (deficient, insufficient, adequate, and high-normal), and COVID-19 severity was ascertained utilizing a multivariable regression analysis. To isolate the possible influence of the sinusoidal pattern of seasonal 25(OH)D changes throughout the year, a cosinor model was used.

Results

Of 1176 patients admitted, 253 had records of a 25(OH)D level prior to COVID-19 infection. A lower vitamin D status was more common in patients with the severe or critical disease (<20 ng/mL [87.4%]) than in individuals with mild or moderate disease (<20 ng/mL [34.3%] p < 0.001). Patients with vitamin D deficiency (<20 ng/mL) were 14 times more likely to have severe or critical disease than patients with 25(OH)D ≥40 ng/mL (odds ratio [OR], 14; 95% confidence interval [CI], 4 to 51; p < 0.001).

Conclusions

Among hospitalized COVID-19 patients, pre-infection deficiency of vitamin D was associated with increased disease severity and mortality.
Date
Source https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263069
Author Amiel A. Dror ,Nicole Morozov,Amani Daoud,Yoav Namir,Orly Yakir,Yair Shachar,Mark Lifshitz,Ella Segal,Lior Fisher,Matti Mizrachi,Netanel Eisenbach,Doaa Rayan,Maayan Gruber,Amir Bashkin,Edward Kaykov,Masad Barhoum,Michael Edelstein,Eyal Sela

doi:10.1371/journal.pone.0263069

Licensing

w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 4.0 International license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Captions

Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness

Items portrayed in this file

depicts

3 February 2022

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current23:09, 4 March 2022Thumbnail for version as of 23:09, 4 March 20221,275 × 1,650, 18 pages (1.1 MB)KoavfUploaded a work by Amiel A. Dror ,Nicole Morozov,Amani Daoud,Yoav Namir,Orly Yakir,Yair Shachar,Mark Lifshitz,Ella Segal,Lior Fisher,Matti Mizrachi,Netanel Eisenbach,Doaa Rayan,Maayan Gruber,Amir Bashkin,Edward Kaykov,Masad Barhoum,Michael Edelstein,Eyal Sela from https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263069 with UploadWizard

There are no pages that use this file.

Metadata